Overview Dividends

(BMI) Badger Meter - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0565251081

Flow Meters, Water Meters, AMR Systems, Sensors, Software

BMI EPS (Earnings per Share)

EPS Growth (3Y CAGR): 28.28%
EPS Trend (3Y Correlation): 93.4%

BMI Revenue

Revenue Growth (3Y CAGR): 18.63%
Revenue Trend (3Y Correlation): 95.9%

Description: BMI Badger Meter November 04, 2025

Badger Meter Inc. (NYSE:BMI) designs, manufactures, and markets flow-measurement and control solutions for a global customer base, ranging from municipal water utilities to original equipment manufacturers (OEMs) in industrial and HVAC markets.

The product portfolio includes smart-metering hardware (ORION cellular and mobile-read endpoints), wireless radio modules, high-frequency pressure and leak-detection sensors, optical and electrochemical water-quality instruments, and the BEACON cloud-based software suite that delivers alerts, analytics, and consumer-engagement tools.

In fiscal 2023 the company generated approximately $1.1 billion in revenue, with an operating margin near 12 % and a backlog that grew roughly 8 % year-over-year, reflecting strong demand for digital water-utility upgrades.

Key sector drivers include rising U.S. and global water-infrastructure investment (the U.S. EPA estimates $300 billion in needed upgrades over the next decade), tightening regulations on water loss and quality, and accelerating adoption of IoT-enabled metering that promises operational cost savings for utilities.

For a deeper quantitative view of Badger Meter’s valuation and risk profile, you may find it worthwhile to explore the company’s profile on ValueRay.

BMI Stock Overview

Market Cap in USD	5,318m
Sub-Industry	Electronic Equipment & Instruments
IPO / Inception	1984-09-07

BMI Stock Ratings

Growth Rating	34.3%
Fundamental	84.8%
Dividend Rating	67.0%
Return 12m vs S&P 500	-25.6%
Analyst Rating	3.67 of 5

BMI Dividends

Dividend Yield 12m	0.78%
Yield on Cost 5y	1.96%
Annual Growth 5y	14.90%
Payout Consistency	97.1%
Payout Ratio	30.2%

BMI Growth Ratios

Growth Correlation 3m	-46.4%
Growth Correlation 12m	-44.8%
Growth Correlation 5y	89.8%
CAGR 5y	18.33%
CAGR/Max DD 3y (Calmar Ratio)	0.57
CAGR/Mean DD 3y (Pain Ratio)	2.18
Sharpe Ratio 12m	0.03
Alpha	-28.29
Beta	0.894
Volatility	29.28%
Current Volume	238.9k
Average Volume 20d	341.3k
Stop Loss	174.8 (-3.9%)
Signal	0.29

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income (138.8m TTM) > 0 and > 6% of Revenue (6% = 54.1m TTM)

FCFTA 0.17 (>2.0%) and ΔFCFTA 0.72pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 37.86% (prev 49.78%; Δ -11.92pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.18 (>3.0%) and CFO 181.0m > Net Income 138.8m (YES >=105%, WARN >=100%)

Net Debt (-201.7m) to EBITDA (207.7m) ratio: -0.97 <= 3.0 (WARN <= 3.5)

Current Ratio 3.22 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (29.6m) change vs 12m ago 0.12% (target <= -2.0% for YES)

Gross Margin 41.26% (prev 39.55%; Δ 1.72pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 101.2% (prev 100.1%; Δ 1.07pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -3.28 (EBITDA TTM 207.7m / Interest Expense TTM -43.5m) >= 6 (WARN >= 3)

Altman Z'' 7.98

(A) 0.35 = (Total Current Assets 494.6m - Total Current Liabilities 153.4m) / Total Assets 978.3m

(B) 0.64 = Retained Earnings (Balance) 624.1m / Total Assets 978.3m

(D) 2.42 = Book Value of Equity 666.4m / Total Liabilities 275.8m

Total Rating: 7.98 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 84.77

1. Piotroski 6.0pt = 1.0

2. FCF Yield 3.25% = 1.62

3. FCF Margin 18.45% = 4.61

4. Debt/Equity 0.01 = 2.50

5. Debt/Ebitda -0.97 = 2.50

6. ROIC - WACC (= 7.13)% = 8.91

7. RoE 21.12% = 1.76

8. Rev. Trend 95.86% = 7.19

9. EPS Trend 93.43% = 4.67

What is the price of BMI shares?

As of November 05, 2025, the stock is trading at USD 181.93 with a total of 238,904 shares traded.
Over the past week, the price has changed by -0.68%, over one month by +0.51%, over three months by -1.90% and over the past year by -9.70%.

Is Badger Meter a good stock to buy?

Yes, based on ValueRay´s Fundamental Analyses, Badger Meter (NYSE:BMI) is currently (November 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 84.77 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BMI is around 183.28 USD . This means that BMI is currently overvalued and has a potential downside of 0.74%.

Is BMI a buy, sell or hold?

Badger Meter has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold BMI.

Strong Buy: 2
Buy: 2
Hold: 5
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the BMI price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	219.5	20.7%
Analysts Target Price	219.5	20.7%
ValueRay Target Price	205.8	13.1%

BMI Fundamental Data Overview November 04, 2025

Market Cap USD = 5.32b (5.32b USD * 1.0 USD.USD)
P/E Trailing = 38.4755
P/E Forward = 34.1297
P/S = 5.9012
P/B = 7.8174
P/EG = 2.29
Beta = 0.894
Revenue TTM = 901.1m USD
EBIT TTM = 142.7m USD
EBITDA TTM = 207.7m USD
Long Term Debt = unknown (none)
Short Term Debt = 5.35m USD (from shortTermDebt, last fiscal year)
Debt = 6.01m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -201.7m USD (from netDebt column, last quarter)
Enterprise Value = 5.12b USD (5.32b + Debt 6.01m - CCE 201.7m)
Interest Coverage Ratio = -3.28 (Ebit TTM 142.7m / Interest Expense TTM -43.5m)
FCF Yield = 3.25% (FCF TTM 166.3m / Enterprise Value 5.12b)
FCF Margin = 18.45% (FCF TTM 166.3m / Revenue TTM 901.1m)
Net Margin = 15.40% (Net Income TTM 138.8m / Revenue TTM 901.1m)
Gross Margin = 41.26% ((Revenue TTM 901.1m - Cost of Revenue TTM 529.3m) / Revenue TTM)
Gross Margin QoQ = 40.67% (prev 41.08%)
Tobins Q-Ratio = 5.24 (Enterprise Value 5.12b / Total Assets 978.3m)
Interest Expense / Debt = 3.41% (Interest Expense 205.0k / Debt 6.01m)
Taxrate = 26.06% (12.4m / 47.4m)
NOPAT = 105.5m (EBIT 142.7m * (1 - 26.06%))
Current Ratio = 3.22 (Total Current Assets 494.6m / Total Current Liabilities 153.4m)
Debt / Equity = 0.01 (Debt 6.01m / totalStockholderEquity, last quarter 702.5m)
Debt / EBITDA = -0.97 (Net Debt -201.7m / EBITDA 207.7m)
Debt / FCF = -1.21 (Net Debt -201.7m / FCF TTM 166.3m)
Total Stockholder Equity = 657.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 14.19% (Net Income 138.8m / Total Assets 978.3m)
RoE = 21.12% (Net Income TTM 138.8m / Total Stockholder Equity 657.0m)
RoCE = 17.29% (EBIT 142.7m / Capital Employed (Total Assets 978.3m - Current Liab 153.4m))
RoIC = 16.43% (NOPAT 105.5m / Invested Capital 641.8m)
WACC = 9.30% (E(5.32b)/V(5.32b) * Re(9.31%) + D(6.01m)/V(5.32b) * Rd(3.41%) * (1-Tc(0.26)))
Discount Rate = 9.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.19%
[DCF Debug] Terminal Value 77.44% ; FCFE base≈152.1m ; Y1≈187.6m ; Y5≈320.1m
Fair Price DCF = 146.7 (DCF Value 4.32b / Shares Outstanding 29.5m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 93.43 | EPS CAGR: 28.28% | SUE: 0.47 | # QB: 0
Revenue Correlation: 95.86 | Revenue CAGR: 18.63% | SUE: 0.59 | # QB: 0

Additional Sources for BMI Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle